Standard treatments for early-stage BC (eBC), where the disease is confined to the breast or the axillary lymph nodes, may include surgery, chemotherapy, anti-HER2 therapy, and endocrine therapy (ET) [6,7]. Here, ERBB2 is linked to breast cancer.